Long-term outcomes after bladder-preserving tri-modality therapy for patients with muscle-invasive bladder cancer: an updated analysis of the Massachusetts General Hospital … NJ Giacalone, WU Shipley, RH Clayman, A Niemierko, M Drumm, ... European urology 71 (6), 952-960, 2017 | 333 | 2017 |
Impact of immune and stromal infiltration on outcomes following bladder-sparing trimodality therapy for muscle-invasive bladder cancer JA Efstathiou, KW Mouw, EA Gibb, Y Liu, CL Wu, MR Drumm, JB da Costa, ... European urology 76 (1), 59-68, 2019 | 140 | 2019 |
Quality of life in long-term survivors of muscle-invasive bladder cancer KS Mak, AB Smith, A Eidelman, R Clayman, A Niemierko, JS Cheng, ... International Journal of Radiation Oncology* Biology* Physics 96 (5), 1028-1036, 2016 | 137 | 2016 |
Clinical outcomes of patients with histologic variants of urothelial cancer treated with trimodality bladder-sparing therapy RE Krasnow, M Drumm, HJ Roberts, A Niemierko, CL Wu, S Wu, J Zhang, ... European urology 72 (1), 54-60, 2017 | 85 | 2017 |
Extensive brainstem infiltration, not mass effect, is a common feature of end-stage cerebral glioblastomas MR Drumm, KS Dixit, S Grimm, P Kumthekar, RV Lukas, JJ Raizer, ... Neuro-oncology 22 (4), 470-479, 2020 | 79 | 2020 |
Long-term impact of a faculty mentoring program in academic medicine JA Efstathiou, MR Drumm, JP Paly, DM Lawton, RM O’Neill, A Niemierko, ... PloS one 13 (11), e0207634, 2018 | 72 | 2018 |
Radical cystectomy versus trimodality therapy for muscle-invasive bladder cancer: a multi-institutional propensity score matched and weighted analysis AR Zlotta, LK Ballas, A Niemierko, K Lajkosz, C Kuk, G Miranda, ... The lancet oncology 24 (6), 669-681, 2023 | 68 | 2023 |
Methylation and transcription patterns are distinct in IDH mutant gliomas compared to other IDH mutant cancers D Unruh, M Zewde, A Buss, MR Drumm, AN Tran, DM Scholtens, ... Scientific reports 9 (1), 8946, 2019 | 60 | 2019 |
PARP-1 inhibition with or without ionizing radiation confers reactive oxygen species-mediated cytotoxicity preferentially to cancer cells with mutant TP53 Q Liu, L Gheorghiu, M Drumm, R Clayman, A Eidelman, MF Wszolek, ... Oncogene 37 (21), 2793-2805, 2018 | 57 | 2018 |
Incidence, clinicopathological risk factors, management and outcomes of nonmuscle invasive recurrence after complete response to trimodality therapy for muscle invasive bladder … A Sanchez, MF Wszolek, A Niemierko, RH Clayman, M Drumm, ... The Journal of urology 199 (2), 407-415, 2018 | 40 | 2018 |
Methylation-dependent tissue factor suppression contributes to the reduced malignancy of IDH1-mutant gliomas D Unruh, S Mirkov, B Wray, M Drumm, J Lamano, YD Li, QF Haider, ... Clinical Cancer Research 25 (2), 747-759, 2019 | 39 | 2019 |
Long‐term quality of life after definitive treatment for prostate cancer: patient‐reported outcomes in the second posttreatment decade JW Jang, MR Drumm, JA Efstathiou, JJ Paly, A Niemierko, M Ancukiewicz, ... Cancer Medicine 6 (7), 1827-1836, 2017 | 35 | 2017 |
Long-term results of adjuvant versus early salvage postprostatectomy radiation: a large single-institutional experience DL Buscariollo, M Drumm, A Niemierko, RH Clayman, S Galland-Girodet, ... Practical Radiation Oncology 7 (2), e125-e133, 2017 | 29 | 2017 |
Negative reinforcement impairs overnight memory consolidation AW Stamm, ND Nguyen, BJ Seicol, A Fagan, A Oh, M Drumm, M Lundt, ... Learning & Memory 21 (11), 591-596, 2014 | 26 | 2014 |
Sedative effect of Clozapine is a function of 5-HT2A and environmental novelty RS Joshi, R Quadros, M Drumm, R Ain, MM Panicker European Neuropsychopharmacology 27 (1), 70-81, 2017 | 18 | 2017 |
Multi-institutional matched comparison of radical cystectomy to trimodality therapy for muscle-invasive bladder cancer. AR Zlotta, LK Ballas, A Niemierko, K Lajkosz, C Kuk, G Miranda, ... Journal of Clinical Oncology 40 (6_suppl), 433-433, 2022 | 17 | 2022 |
Complications and outcomes of salvage cystectomy after trimodality therapy A Pieretti, R Krasnow, M Drumm, A Gusev, DM Dahl, F McGovern, ... The Journal of Urology 206 (1), 29-36, 2021 | 17 | 2021 |
Postoperative risk of IDH-mutant glioma–associated seizures and their potential management with IDH-mutant inhibitors MR Drumm, W Wang, TK Sears, K Bell-Burdett, R Javier, KY Cotton, ... The Journal of clinical investigation 133 (12), 2023 | 12 | 2023 |
Determining venous thromboembolism risk in patients with adult-type diffuse glioma KB Burdett, D Unruh, M Drumm, A Steffens, J Lamano, J Judkins, ... Blood 141 (11), 1322-1336, 2023 | 11 | 2023 |
Outcomes and tolerability of selective bladder preservation by combined modality therapy for invasive bladder cancer in elderly patients DT Miyamoto, MR Drumm, RH Clayman, A Niemierko, N Heney, R Lee, ... International Journal of Radiation Oncology, Biology, Physics 99 (2), S120, 2017 | 6 | 2017 |